Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
65.07
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
14,697
Open
65.07
Bid (Size)
64.38 (2)
Ask (Size)
64.90 (2)
Prev. Close
65.07
Today's Range
65.07 - 65.07
52wk Range
8.280 - 99.41
Shares Outstanding
99,581,693
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024
April 24, 2024
VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO
April 24, 2024
Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 cents by 7.14%. Research and development expenses were $24.1 million for the...
Via
Benzinga
Performance
YTD
+255.96%
+255.96%
1 Month
-5.95%
-5.95%
3 Month
+203.36%
+203.36%
6 Month
+509.84%
+509.84%
1 Year
+227.31%
+227.31%
More News
Read More
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
Via
InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
April 24, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Via
The Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
Via
The Motley Fool
Looking At Viking Therapeutics's Recent Unusual Options Activity
April 22, 2024
Via
Benzinga
Market Whales and Their Recent Bets on VKTX Options
April 18, 2024
Via
Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
April 15, 2024
Via
Benzinga
1 No-Brainer Vanguard Fund to Buy Right Now
April 23, 2024
Via
The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
April 23, 2024
Via
InvestorPlace
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
Via
MarketBeat
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
April 16, 2024
Via
InvestorPlace
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
April 09, 2024
Via
Benzinga
Is it Too Late to Buy Viking Therapeutics Stock?
April 06, 2024
Via
The Motley Fool
Viking Therapeutics: Strong Results In Obesity
April 13, 2024
Via
Talk Markets
3 Magnificent Stocks That Could Double or More by 2030
April 13, 2024
Via
The Motley Fool
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
April 12, 2024
Via
InvestorPlace
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
April 11, 2024
Via
InvestorPlace
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
April 09, 2024
Via
The Motley Fool
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
April 09, 2024
Via
The Motley Fool
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 09, 2024
Via
MarketBeat
Exposures
Product Safety
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
April 08, 2024
Via
The Motley Fool
MarketBeat Week in Review – 4/1 - 4/5
April 06, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
April 05, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.